Title:Bergenin - A Biologically Active Scaffold: Nanotechnological Perspectives
Volume: 22
Issue: 2
Author(s): Reecha Madaan, Rajeev K. Singla*, Suresh Kumar, Ankit Kumar Dubey, Dinesh Kumar, Pooja Sharma, Rajni Bala, Shailja Singla and Bairong Shen*
Affiliation:
- Institutes for Systems Genetics, Frontiers Science
Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan,
China
- iGlobal Research and Publishing Foundation, New Delhi-110059, India
- Institutes for Systems Genetics, Frontiers Science
Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan,
China
Keywords:
Anticancer, Anti-inflammatory, Bergenin, Hepatoprotective, Molecular docking, Nanotechnology.
Abstract: Bergenin, 4-O-methyl gallic acid glucoside, is a bioactive compound in various plants
belonging to different families. The present work compiles scattered information on pharmacology,
structure-activity relationship and nanotechnological aspects of bergenin, collected from various
electronic databases such as Sci Finder, PubMed, Google Scholar, etc. Bergenin has been reported
to exhibit hepatoprotective, anti-inflammatory, anticancer, neuroprotective, antiviral, and antimicrobial
activities. Molecular docking studies have shown that isocoumarin pharmacophore of bergenin
is essential for its bioactivities. Bergenin holds a great potential to be used as a lead molecule and
also as a therapeutic agent for the development of more efficacious and safer semisynthetic derivatives.
Nanotechnological concepts can be employed to overcome the poor bioavailability of bergenin.
Finally, it is concluded that bergenin can emerge as clinically potential medicine in modern
therapeutics.